Psychoneuroendocrinology
Volume 31, Issue 6 , Pages 748-760 , July 2006

Altered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients

  • M. Spiliotaki

      Affiliations

    • Laboratory of Biological Chemistry, Medical School, University of Athens, 75 Mikras Asias street, Goudi, GR 11527 Athens, Attiki, Greece
    • ,
  • V. Salpeas

      Affiliations

    • Laboratory of Biological Chemistry, Medical School, University of Athens, 75 Mikras Asias street, Goudi, GR 11527 Athens, Attiki, Greece
    • ,
  • P. Malitas

      Affiliations

    • Department of Psychiatry, Medical School, Eginition Hospital, University of Athens, 74 Vas Sofias Avenue, Athens, Greece
    • ,
  • V. Alevizos

      Affiliations

    • Department of Psychiatry, Medical School, Eginition Hospital, University of Athens, 74 Vas Sofias Avenue, Athens, Greece
    • ,
  • P. Moutsatsou

      Affiliations

    • Laboratory of Biological Chemistry, Medical School, University of Athens, 75 Mikras Asias street, Goudi, GR 11527 Athens, Attiki, Greece
    • Corresponding Author InformationCorresponding author. Tel.: +30 210 7462682; fax: +30 210 7462703.

Received 21 July 2005 ,Revised 20 February 2006 ,Accepted 20 February 2006.

References 

  1. Bamberger CM, Bamberger A, DeCastro M, Chroussos GP. Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 1995;95:2435–2441
  2. Barden N. Modulation of glucocorticoid receptor gene expression by antidepressant drugs. Pharmacopsychiatry. 1996;29:12–22
  3. Barden N, Reul JMH, Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical sytems?. Trends Neurosci. 1995;18:6–11
  4. Bartholoma P, Erlandsson N, Kaufmann K, Rossler OG, Baumann B, Wirth T, et al. Neuronal cell death induced by anti-depressants: lack of correlation with Egr-1, NF-kappa B and extracellular signal-regulated protein kinase activation. Biochem. Pharmacol. 2002;63:1507–1516
  5. Bauer ME, Papadopoulos A, Poon L, Perks P, Lightman SL, Checkley S, et al. Altered glucocorticoid immunoregulation in treatment resistant depression. Psychoneuroendocrinology. 2003;28:49–65
  6. Beato M, Sanchez-Pacheco A. Interaction of steroid hormone receptors with the transcription initiation complex. Endocr. Rev. 1996;17:587–609
  7. Beato M, Herrlich P, Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell. 1995;83:851–857
  8. Blanco JC, Minucci S, Lu J, Yang XJ, Walker KK, Chen H, et al. The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev. 1998;12:1638–1651
  9. Boyum, A., 1968. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. (Suppl. 97) 77–89.
  10. Brady LS, Gold PW, Herkenham M, Lynn AB, Whitfield HR. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: Therapeutic implications. Brain Res. 1992;572:117–125
  11. Bruna A, Nicolas M, Munoz A, Kyriakis JM, Caelles C. Glucocorticoid receptor-JNK interaction mediates inhibition the JNK pathway by glucocorticoids. EMBO J. 2003;17:6035–6044
  12. Brunello N, Tascedda F. Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders. Int. J. Neuropsychopharmacol. 2003;6:181–189
  13. Budziszewska B, Siwanowicz J, Przegalinski E. The effect of chronic treatment with antidepressant drugs on the corticosteroid receptor levels in the rat hippocampus. Pol. J. Pharmacol. 1994;46:147–152
  14. Budziszewska B, Jaworska-Feil L, Kajta M, Lason W. Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription—a possible mechanism. Br. J. Pharmacol. 2000;130:1385–1393
  15. Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, et al. Negative cross-talk between ReIA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol. Endocrinol. 1995;9:401–412
  16. Calfa G, Kademina S, Ceschin D, Vega G, Rabinovich GA, Volosin M. Characterization and funcitonal significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment. Psychoneuroendocrinology. 2003;28:697–701
  17. Chen G, Hasanat KA, Bebchuk JM, Moore GJ, Glitz D, Manji HK. Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants. Psychosom. Med. 1999;61:599–617
  18. Chen G, Chen RW, Qin ZH, Ren M, Kanai H, Chalecka-Franaszek E, et al. J. Neurochem. 2003;84:566–575
  19. Chuang D-M, Chen R-W, Chalecka-Franaszek E, Ren M, Hashimoto R, Senatorov V, et al. Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord. 2002;4:129–136
  20. Cowen PJ. Cortisol, serotonin and depression: all stressed out?. Br. J. Psychiatry. 2002;180:99–100
  21. De Bosscher K, Van den Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 2003;24:488–522
  22. Deuschle M, Schweiger U, Weber B, Gotthardt U, Korner A, Schmider J, et al. Diurnal activity and pulsatility of the hypothalamus–pituitary–adrenal system in male depressed patients and healthy controls. J. Clin. Endocrinol. Metab. 1997;82:234–238
  23. Frechilla D, Otano A, Del Rio J. Effect of chronic antidepressant treatment on transcription factor binding activity in rat hippocampus and frontal cortex. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1998;22:787–802
  24. Fruchter O, Kino T, Zoumakis F, Alesci S, De Martino M, Chrousos G, et al. The human glucocorticoid receptor (GR) isoform (beta) differentially suppresses GR{alpha}-induced transactivation stimulated by synthetic glucocorticoids. J. Clin. Endocrinol. Metab. 2005;90:3505–3509
  25. Glasgow J, Perez-Polo R. One path to cell death in the nervous system. Neurochem. Res. 2000;25:1373–1383
  26. Gonzalez MV, Jimenez B, Berciano MT, Gonzalez-Sancho JM, Caelles C, Lafarga M, et al. Glucocorticoids antagonize AP-1 by inhibiting the activation/phosphorylation of JNK without affecting its subcellular distribution. J. Cell. Biol. 2000;150:1199–1208
  27. Gottlicher M, Heck S, Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J. Mol. Med. 1998;76:480–489
  28. Greden JF, Gardner R, King D, Grunhaus L, Carroll BJ, Kronfol Z. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test–retest reproducibility. Arch. Gen. Psychiatry. 1983;40:493–500
  29. Henning U, Krieger K, Loeffler S, Rivas F, Orozco G, de Castro MG, et al. Increased levels of glucocorticoid receptors and enhanced glucocorticoid receptor auto-regulation after hydrocortisone challenge in B-lymphoblastoids from patients with affective disorders. Psychoneuroendocrinology. 2005;30:325–332
  30. Herdegen T, Waetzig V. AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene. 2001;20:2424–2432
  31. Herr AS, Tsolakidou AF, Yassouridis A, Holsborer F, Reinm T. Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro. Neuroendocrinology. 2003;78:12–22
  32. Heuser I, Yassouridis A, Holsboer F. The combined dexamethaso-ne/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatr. Res. 1994;28:341–356
  33. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 2000;23:477–501
  34. Holsboer F, Liebl R, Hofschuster E. Repeated dexamethasone suppression test during depressive illness. Normalization of test result compared with clinical improvement. J. Affect Disord. 1982;4:93–101
  35. Kino T, De Martino MU, Charmandari E, Mirani M, Chrousos GP. Tissue glucocorticoid resistance/hypersensitivity syndromes. J. Steroid Biochem. Mol. Biol. 2003;85:457–467
  36. Kino T, Tiulpakov A, Ichijo T, Chheng L, Kozasa T, Chrousos GP. G protein beta interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus. J. Cell. Biol. 2005;169:885–896
  37. Krstic MD, Rogatsky I, Yamamoto KR, Garabedian MJ. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol. 1997;17:3947–3954
  38. Licinio J, Wong ML. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and cotnribute to neurotoxicity and neuroprotection. Mol. Psychiatry. 1999;4:317–327
  39. Lopez JF, Chalmers DT, Little KI, Watson SJ. Regulation of serotonin 1A, glucocorticoid and mineralocorticoid receptor in rat and human hipocampus: implications for the neurobiology of depression. Biol. Psychiatry. 1998;43:547–573
  40. Lowy MT. Reserpine-induced decrease in type I and II corticosteroid receptors in neuronal and lymphoid tissues of adrenalectomized rats. Neuroendocrinology. 1990;51:190–196
  41. Lowy MT, Reder AT, Antel JP, Meltzer HY. Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone. Am. J. Psychiatry. 1984;141:1365–1370
  42. Manji HK, Drevets WC, Charney DS. The cellular neurobiology of depression. Nat. Med. 2001;7:541–547
  43. Manji HK, Moore GJ, Chen G. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers. Br. J. Psychiatry. 2001;41(Suppl. 1):107–119
  44. Marini AM, Jiang X, Wu X, Tian F, Zhu D, Okagaki P, et al. Role of brain-derived neurotrophic factor and NF-kappa B in neuronal plasticity and survival: from genes to phenotype. Restor. Neurol. Neurosci. 2004;22:121–130
  45. McKenna NJ, Lanz RB, O'Malley BW. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 1999;20:321–344
  46. Montkowski A, Barden N, Wotjak C, Stec I, Ganster J, Meaney M, et al. Long-term antidepressant treatment reduces behavioral deficits in transgenic mice and impaired glucocorticoid receptor function. J. Neuroendocrinol. 1995;7:841–845
  47. Moutsatsou P, Tsolakidou A, Trikkas G, Troungos C, Sekeris CE. Glucocorticoid receptor alpha and beta isoforms are not mutated in bipolar affective disorder. Mol. Psychiatry. 2000;5:196–202
  48. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 1984;226:1342–1344
  49. Okamoto H, Shino Y, Hashimoto K, Kumakiri C, Shimizu E, Shirasawa H, et al. Dynamic changes in AP-1 transcription factor DNA binding activity in rat brain following administration of antidepressant amitriptyline and brain-derived neurotrophic factor. Neuropharmacology. 2003;45:251–259
  50. Olley A, Malhi GS, Mitchell PB, Batchelor J, Lagopoulos J, Austin M-PV. When euthymia is just not good enough. The neuropsychology of bipolar disorder. J. Nerv. Ment. Dis. 2005;193:323–330
  51. Ozaki N, Chuang DM. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J. Neurochem. 1997;69:2336–2344
  52. Pariante CM, Miller AH. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry. 2001;49:391–404
  53. Pariante CM, Pearce BD, Pisell TL, Owens MJ, Miller AH. Steroid-independent translocation of the glucocorticoid receptor by the anti-depressant desipramine. Mol. Pharmacol. 1997;52:571–581
  54. Peiffer A, Veilleux S, Barden N. Antidepressant and other centrally acting drugs regulated glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology. 1991;16:505–515
  55. Pepin MC, Govindan MV, Barden N. Increased glucocorticoid receptor gene promoter activity after antidepressant treatment. Mol. Pharmacol. 1992;41:1016–1022
  56. Perez J, Tardito D, Mori S, Racagni G, Smeraldi E, Zanardi R. Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder. Arch. Gen. Psychiatry. 1999;56:248–253
  57. Post A, Crochemore C, Uhr M, Holsboer F, Behl C. Differential induction of NF-kappa B activity and neural cell death by antidepressants in vitro. Eur. J. Neurosci. 2000;12:4331–4337
  58. Przegalinski E, Budziszewska B. The effect of long-term treatment with antidepressant drugs on the hippocampal mineralocorticoid and glucocorticoid receptors in rats. Neurosci. Lett. 1993;161:215–218
  59. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 1994;60:436–444
  60. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell. 1998;93:531–541
  61. Rogatsky I, Logan SK, Garabedian MJ. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc. Natl Acad. Sci. USA. 1998;95:2050–2055
  62. Rossby SP, Nalepa I, Huang M, Perrin C, Burt AM, Schmidt DE, et al. Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant. Brain Res. 1995;687:79–82
  63. Rubin RT, Phillips JJ, Sadow TF, McCracken JT. Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Arch. Gen. Psychiatry. 1995;52:213–218
  64. Schreiber E, Matthias P, Muumler MM, Schaffner W. Rapid detection of octamer binding proteins with ‘mini-extracts’, prepared from a small number of cells. Nucleic Acids Res. 1989;17:6419
  65. Seckl JR, Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology. 1992;55:621–626
  66. Smit P, Russcher H, de Jong FH, Brinkmann AO, Lamberts SW, Koper JW. Differential regulation of synthetic glucocorticoids on gene expression levels of glucocorticoid-induced leucine zipper and interleukin-2. J. Clin. Endocrinol. Metab. 2005;90:2994–3000
  67. Spencer RL, Miller AH, Stein M, McEwen BS. Corticosterone regulation of type I and type II adrenal steroid receptors in brain, pituitary, and immune tissue. Brain Res. 1991;549:236–246
  68. Sun Y, Zhang L, Johnston NL, Torrey EF, Yolken RH. Serial analysis of gene expression in the frontal cortex of patients with bipolar disorder. Br. J. Psychiatry. 2001;41:137–141
  69. Tamura T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S. The effects of antidepressant drug treatments on activator protein-1 binding activity in the rat brain. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2002;26:375–381
  70. Wang X, Wu H, Lakdawala VS, Hu F, Hanson ND, Miller AH. Inhibition of Jun N-terminal kinase (JNK) enhances glucocorticoid receptor-mediated function in mouse hippocampal HT22 cells. Neuropsychopharmacology. 2004;30(2):242–249
  71. Watson S, Gallagher P, Ritchie JC, Ferrier N, Young AH. Hypothalamic–pituitary–adrenal axis function in patients with bipolar disorder. Br. J. Psychiatry. 2004;184:496–502
  72. Webster MJ, Knable MB, O'Grady J, Orthmann J, Weickert CS. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol. Psychiatry. 2002;7:985–994
  73. Wissink S, Meijer O, Pearce D, van Der Burg B, van Der Saag PT. Regulation of the rat serotonin-1A receptor gene by corticosteroids. J. Biol. Chem. 2000;275:1321–1326

PII: S0306-4530(06)00033-3

doi: 10.1016/j.psyneuen.2006.02.006

Psychoneuroendocrinology
Volume 31, Issue 6 , Pages 748-760 , July 2006

Article Tools

* Image Usage & Resolution